Buprenorphine Hydrochloride Tablet
Product Images NDC 72888-182

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 72888-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Sublingual Tablets 2 mg (NDC 72888-182-30)

Each tablet contains 216 mg of buprenorphine hydrochloride, USP equivalent to 10.2mg of buprenorphine base. This medication comes in a package insert with complete prescribing information. It is recommended to store the tablets at 20-25°C (68° to 77°F). This product is available in a 30-tablet pack and is for prescription use only. For more details, the insert is available at https://www.advagenpharma.com. The tablets are sublingual and are distributed by Advagen Pharma Ltd., in East Windsor, NJ, USA. They are manufactured by Rubicon Research Pvt. Ltd. in Thane, India.*

FDA Label Image

Buprenorphine Sublingual Tablets 2 mg (NDC 72888-182-90)

Each tablet contains 2.16mg of buprenorphine hydrochloride, equivalent to 2 mg of buprenorphine base. The tablets are sublingual and come in a package of 90 tablets. The medication should be stored at 20°to 25°C (68-77°F). Detailed prescribing information can be found in the package insert. Distributed by Advagen Pharma Ltd. in East Windsor, NJ, and manufactured by Rubicon Research Pvt. Ltd. in Thane, India. Manufacturing license number: KD-682. Additional details can be found at www.advagenpharma.com.*

FDA Label Image

Buprenorphine Sublingual Tablets 8 mg (NDC 72888-183-30)

This text provides information about a tablet containing 8.64mg of buprenorphine hydrochloride, equivalent to 8 mg of the prescribing base. It also includes details such as the manufacturer (Rubicon Research Pvt. Ltd.), distributor (Advagen Pharma Ltd.), storage conditions, and reference to a medication guide. The National Drug Code (NDC) for this tablet is 72888-183-30. The package insert can be consulted for more information.*

FDA Label Image

Buprenorphine Sublingual Tablets 8 mg (NDC 72888-183-90)

This is a description of buprenorphine hydrochloride sublingual tablets containing 8.64 mg of buprenorphine, which is equivalent to 8 mg of buprenorphine base. The usual dose information is available in the package insert. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The text also mentions the importance of dispensing the medication guide to patients and keeping the medication out of reach of children. The product is distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Pvt. Ltd. in India. More information can be found on their website.*

FDA Label Image

Ifu-image (Buprenorphine Sublingual Tablets Ifu Image)

FDA Label Image

Chemical Structure (Buprenorphine Sublingual Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.